Conecte-se

Bibliografias temáticas / Pathogenesis / Artigos de revistas

Siga este link para ver outros tipos de publicações sobre o tema: Pathogenesis.

Artigos de revistas sobre o tema "Pathogenesis"

Autor: Grafiati

Publicado: 4 de junho de 2021

Última modificação: 9 de novembro de 2024

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Pathogenesis".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.

1

Orazov, M. R., V. E. Radzinsky, E. D. Dolgov e Yu G. Abramashvili. "Pathogenesis and pathogenetic options in endometriosis management". Voprosy ginekologii, akušerstva i perinatologii 22, n.º 1 (2023): 92–104. http://dx.doi.org/10.20953/1726-1678-2023-1-92-104.

Texto completo da fonte

Resumo:

This article provides a literature review on the etiopathogenesis of endometriosis. Particular attention was paid to genetic and molecular biological aspects of endometriosis. The issues of conservative management of patients with confirmed endometriosis were also considered. The use of dienogest in the treatment of patients with endometriosis was substantiated. Key words: endometriosis, etiopathogenesis, genetic and molecular determinants, dienogest

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Tanashyan, M. M., K. V. Antonova, N. E. Spryshkov, A. А. Panina, O. V. Lagoda e E. P. Shchukina. "Diabetic Polyneuropathy: from Pathogenesis to Pathogenetic Therapy". Effective Pharmacotherapy 20, n.º 8 (21 de junho de 2024): 54–62. http://dx.doi.org/10.33978/2307-3586-2024-20-8-54-62.

Texto completo da fonte

Resumo:

The growing worldwide prevalence of prediabetes and diabetes mellitus (DM) has led to an increase in the incidence of related chronic complications, the most common of which is diabetic polyneuropathy (DPN). The development of DPN is caused by chronic hyperglycemia and potentially modifiable cardiovascular risk factors, including elevated triglyceride levels, body mass index, smoking and hypertension. Social determinants of health are also risk factors for DPN. The review presents data on the pathophysiology of DPN with consideration of the causes of the sequence of symptoms. Discussed the mechanisms and significance of mitochondrial damage, metabolic disorders and regulatory functions of Schwann cells, and issues of autophagy. Noted the role of factors such as hyperglycemia, dyslipidemia, insulin resistance and microvascular disorders, described the signaling pathways and epigenetic changes associated with DPN. Emphasized the role of lifestyle changes and behavioral interventions in the comprehensive management of patients with lesions of the peripheral nervous system in DM. Highlighted modern approaches to the treatment of diabetic neuropathy from the point of view of the mechanisms leading to its progression, as well as unresolved issues and prospects are outlined.

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Roy, Saumendu Deb. "Pathogenesis of COVID-19". INDIAN RESEARCH JOURNAL OF PHARMACY AND SCIENCE 7, n.º 4 (setembro de 2020): 2354–58. http://dx.doi.org/10.21276/irjps.2020.7.3.3.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Strokov, I. A., e V. V. Oganov. "Pathogenesis, evaluation and pathogenetic therapy of diabetic polyneuropathy". Neurology, Neuropsychiatry, Psychosomatics 13, n.º 3 (24 de junho de 2021): 99–106. http://dx.doi.org/10.14412/2074-2711-2021-3-99-106.

Texto completo da fonte

Resumo:

The increase in the number and life expectancy of patients with diabetes mellitus (DM) worldwide determines the high prevalence of late complications of diabetes, including diabetic polyneuropathy (DPN), the most common type of polyneuropathy. Oxidative stress is considered the main reason for the cellular pathology development in diabetes mellitus, which determines the use of antioxidants for the DPN treatment. Alpha-lipoic acid (ALA), a natural fat-soluble antioxidant, is the most effective drug for reducing DPN symptoms. Furthermore, the symptom-modifying effect of ALA has been shown in numerous randomized controlled trials. The article discusses the possible disease-modifying effect of ALA.

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Galante, Iv. "A. Bakk & Gh. Tamasescu Ueber die Aetiologie und Pathogenese der Epilepsie und deren Therapie. Wiener Med. W. No. 17, 1933". Kazan medical journal 29, n.º 5-6 (12 de janeiro de 2022): 489. http://dx.doi.org/10.17816/kazmj89620.

Texto completo da fonte

Resumo:

Bakk and Tamasescu (A. Bakk Gh. Tamasescu Ueber die Aetiologie und Pathogenese der Epilepsie und deren Therapie. Wiener Med. W. No. 17, 1933) give a good concise overview of the etiology, pathogenesis and treatment of epilepsy. Epilepsy is an organic syndrome with a different etiology and multiple pathogenetic factors, which explains that the methods of treatment for epilepsy vary enormously.

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

A, Abdelmoktader. "Mycobacterial Tuberculosis Epidemiology and Pathogenesis". Virology & Immunology Journal 4, n.º 4 (19 de novembro de 2020): 1–7. http://dx.doi.org/10.23880/vij-16000259.

Texto completo da fonte

Resumo:

Mycobacterium tuberculosis (MTB) is an acid fast bacterium (AFB); it has tough cell wall and circular chromosome. It is transmitted through the airborne route and cause tuberculosis (TB). The distribution of tuberculosis is not uniform across the globe; about 80% of the population in many Asian and African countries and it is the second most common cause of death from infectious disease after HIV. Organisms deposited mainly in the upper lung zones, kidneys and bones. In persons with intact cell-mediated immunity (CMI), collections of activated T cells and macrophages form granulomas that limit multiplication and spread of the organism. The Status of CMI will determine if the patient will get active or latent TB infection.

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Kim, Young Kyoon, e Younsuck Koh. "Pathogenesis". Tuberculosis and Respiratory Diseases 50, n.º 5 (2001): 525. http://dx.doi.org/10.4046/trd.2001.50.5.525.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

Witz, Craig, e Robert Schenken. "Pathogenesis". Seminars in Reproductive Medicine 15, n.º 03 (agosto de 1997): 199–208. http://dx.doi.org/10.1055/s-2008-1068749.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Gollnick, Harald P. M., Christos C. Zouboulis, Hirohiko Akamatsu, Ichiro Kurokawa e Anja Schulte. "Pathogenesis and Pathogenesis Related Treatment of Acne". Journal of Dermatology 18, n.º 9 (setembro de 1991): 489–99. http://dx.doi.org/10.1111/j.1346-8138.1991.tb03122.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Bilalova, K. A., e L. A. Yusupova. "ROSACEA: FEATURES OF PATHOGENESIS AND THERAPY". European Journal of Natural History, n.º 2 2022 (2022): 18–21. http://dx.doi.org/10.17513/ejnh.34252.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

Tuor, Paula, e Jenkins Zhao. "Pathogenesis of Brain: Autism Spectrum Disorders". Neuroscience and Neurological Surgery 2, n.º 2 (20 de abril de 2018): 01–02. http://dx.doi.org/10.31579/2578-8868/029.

Texto completo da fonte

Resumo:

Autism spectrum disorders (ASDs) affect as many as 1 in 45 children and are characterized by deficits in sociability and communication, as well as stereotypic movements. Many children also show severe anxiety.

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

Syabbalo, Nightingale. "Severe Neutrophilic Asthma: Pathogenesis and Treatment". Journal of Thoracic Disease and Cardiothoracic Surgery 3, n.º 1 (15 de janeiro de 2022): 01–13. http://dx.doi.org/10.31579/2693-2156/030.

Texto completo da fonte

Resumo:

Asthma is a common chronic airway disease affecting about 358 million people worldwide, and an estimated 7 million children globally. Approximately 10% of patients with asthma have severe refractory disease, which is difficult to control on high doses of inhaled corticosteroids and other modifiers. Among these, are patients with severe neutrophilic asthma. Neutrophilic asthma is a severe phenotype of asthma, characterized by frequent exacerbations, persistent airway obstruction, and poor lung function. Immunopathologically, it is characterized by the presence of high levels of neutrophils in the airways and lungs. Interleukin-17 produced by Th17 cells, plays a key role in the pathogenesis of neutrophilic asthma by expressing the secretion of chemoattractant cytokines and chemokines for the recruitment, and activation of neutrophils. Interleukin-8 is a powerful chemoattractant and activator of neutrophils. Activated neutrophils produce an oxidative burst, releasing multiple reactive oxygen species, proteinases, cytokines, which cause airway epithelial cell injury, inflammation, airway hyperresponsiveness, and remodeling. Furthermore, exasperated neutrophils due to viral, bacterial or fungal infections, and chemical irritants can release extracellular nucleic acids (DNA), designated as NETs (neutrophil extracellular traps), which are more toxic to the airway epithelial cells, and orchestrate airway inflammation, and release alarmin cytokines. Dysregulated NETs formation is associated with severe asthma. Most patients with neutrophilic asthma are unresponsive to the standard of care, including high dose inhaled corticosteroids, and to targeted biologics, such as mepolizumab, and dupilumab, which are very effective in treating eosinophilic asthma. There is unmet need to explore for novel biologics for the treatment of neutrophilic asthma, and in refining therapies, such as bronchial thermoplasty.

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

O.A., Babadjanov, e Pulatova S.X. "ACNE: ETIOLOGY, PATHOGENESIS AND MODERN THERAPY". International Journal of Medical Sciences And Clinical Research 03, n.º 03 (1 de março de 2023): 46–50. http://dx.doi.org/10.37547/ijmscr/volume03issue03-07.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

HAYASHI, Koichi. "Pathogenesis of Hypertension -Kidney as a Pathogenetic Organ of Hypertension." Internal Medicine 40, n.º 2 (2001): 153–56. http://dx.doi.org/10.2169/internalmedicine.40.153.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

Bespalov, Vladimir G., e Elizaveta I. Kovalevskaya. "Modern conceptions of etiology and pathogenesis of benign breast disease: the possibilities of pathogenetic treatment". Gynecology 21, n.º 1 (15 de fevereiro de 2019): 52–58. http://dx.doi.org/10.26442/20795696.2019.1.190217.

Texto completo da fonte

Resumo:

Relevance. The review article is devoted to modern conceptions of etiology and pathogenesis of benign breast disease (BBD), a common female pathology, as well as the pathogenetic treatment of BBD. Aim. Substantiation of the new possibilities of the pathogenetic treatment of BBD. Materials and methods. It was conducted the analysis of domestic and world literature in the following areas: etiology, pathogenesis, treatment of BBD, prevention of breast cancer (BC). Results. Dozens of etiological factors of various natures cause BBD: genetic, reproductive, hormonal, gynecological diseases, extragenital pathology, environment and lifestyle, medical interventions. The etiological factors of BBD mostly coincide with the risk factors of BC. The lack of progesterone, the predominance of estradiol and chronic hyperestrogenemia, leading to hyperproliferation of the ductal and lobular epithelium of the mammary glands, underlie the pathogenesis of BBD. The pathogenesis of proliferative forms of BBD and BC have common features. In patients with proliferative and precancerous forms of BBD, the risk of BC increases significantly. Chronic iodine deficiency is one of the common pathogenetic pathways for the development of BBD. The drug mamoclam containing organically bound iodine from laminaria thallus is an effective and safe remedy for the pathogenetic treatment of BBD. Conclusion. Pathogenetic treatment of BBD not only improves the quality of life of patients, but also reduces the risk of BC.

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Smith, Laurie D., e Thomas A. Ficht. "Pathogenesis ofBrucella". Critical Reviews in Microbiology 17, n.º 3 (janeiro de 1990): 209–30. http://dx.doi.org/10.3109/10408419009105726.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Garcia, Sonia Arely, Vincent Y. Ng, Masahiro Iwamoto e Motomi Enomoto-Iwamoto. "Osteochondroma Pathogenesis". American Journal of Pathology 191, n.º 12 (dezembro de 2021): 2042–51. http://dx.doi.org/10.1016/j.ajpath.2021.08.003.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

Haidar, Ruvin. "Microbial Pathogenesis". International Journal of Health Sciences and Research 11, n.º 12 (20 de dezembro de 2021): 217–19. http://dx.doi.org/10.52403/ijhsr.20211228.

Texto completo da fonte

Resumo:

For a pathogenic microbe to cause disease in a susceptible host, it must gain access to that host first. The pathogenicity of a microbe is determined by the virulence factors alongside other innate mechanisms. Apart from the initiation of infection, these virulence factors also enable the pathogenic microorganism to survive in the new environment within the susceptible host. They also enable the pathogenic microorganism to invade the host, colonize, and evade the host defense mechanisms. These virulence factors include; invasins, capsules, siderophores, adhesins, enzymes, endotoxins, and exotoxins. Key words: Pathogenicity factors and Pathological effect on cells.

Estilos ABNT, Harvard, Vancouver, APA, etc.

19

Horwitz, Ralph I., Burton H. Singer, Allison Hayes-Conroy, Mark R. Cullen, McKayla Mawn, Katharine Colella e Ida Sim. "Biosocial Pathogenesis". Psychotherapy and Psychosomatics 91, n.º 2 (2022): 73–77. http://dx.doi.org/10.1159/000521567.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

Johnson, Cydney, Virginia Hargest, Valerie Cortez, Victoria Meliopoulos e Stacey Schultz-Cherry. "Astrovirus Pathogenesis". Viruses 9, n.º 1 (22 de janeiro de 2017): 22. http://dx.doi.org/10.3390/v9010022.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

Eyre, David, e David J. Schurman. "Pathogenesis/Homeostasis". Clinical Orthopaedics and Related Research 427 (outubro de 2004): S104. http://dx.doi.org/10.1097/01.blo.0000144978.73030.b7.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

Milner, Danny A. "Malaria Pathogenesis". Cold Spring Harbor Perspectives in Medicine 8, n.º 1 (22 de maio de 2017): a025569. http://dx.doi.org/10.1101/cshperspect.a025569.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

Scott, J. R. "Scrapie pathogenesis". British Medical Bulletin 49, n.º 4 (outubro de 1993): 778–91. http://dx.doi.org/10.1093/oxfordjournals.bmb.a072646.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

24

Moayeri, Mahtab, Stephen H. Leppla, Catherine Vrentas, Andrei P. Pomerantsev e Shihui Liu. "Anthrax Pathogenesis". Annual Review of Microbiology 69, n.º 1 (15 de outubro de 2015): 185–208. http://dx.doi.org/10.1146/annurev-micro-091014-104523.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

25

Fauci, Anthony S. "Cellular Pathogenesis". AIDS Research and Human Retroviruses 7, n.º 2 (fevereiro de 1991): 202–15. http://dx.doi.org/10.1089/aid.1991.7.202.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

26

Miller, L., M. Good e G. Milon. "Malaria pathogenesis". Science 264, n.º 5167 (24 de junho de 1994): 1878–83. http://dx.doi.org/10.1126/science.8009217.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

27

FRITSCH, P. "WS102 Pathogenesis". Journal of the European Academy of Dermatology and Venereology 9 (setembro de 1997): S100. http://dx.doi.org/10.1016/s0926-9959(97)89260-4.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

28

Ross, Christopher A. "Polyglutamine Pathogenesis". Neuron 35, n.º 5 (agosto de 2002): 819–22. http://dx.doi.org/10.1016/s0896-6273(02)00872-3.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

29

Karumanchi, S. Ananth, e Marshall D. Lindheimer. "Preeclampsia Pathogenesis". Hypertension 51, n.º 4 (abril de 2008): 991–92. http://dx.doi.org/10.1161/hypertensionaha.107.100735.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

30

Paumgartner, G., e T. Sauerbruch. "Gallstones: pathogenesis". Lancet 338, n.º 8775 (novembro de 1991): 1117–21. http://dx.doi.org/10.1016/0140-6736(91)91972-w.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

31

Forrester, J. "Uveitis: pathogenesis". Lancet 338, n.º 8781 (dezembro de 1991): 1498–501. http://dx.doi.org/10.1016/0140-6736(91)92309-p.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

32

Nowak, Martin A. "AIDS Pathogenesis". Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 10, Supplement (1995): S6. http://dx.doi.org/10.1097/00042560-199510001-00002.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

33

Buller, R. M., e G. J. Palumbo. "Poxvirus pathogenesis." Microbiological Reviews 55, n.º 1 (1991): 80–122. http://dx.doi.org/10.1128/mmbr.55.1.80-122.1991.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

34

Buller, R. M., e G. J. Palumbo. "Poxvirus pathogenesis." Microbiological Reviews 55, n.º 1 (1991): 80–122. http://dx.doi.org/10.1128/mr.55.1.80-122.1991.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

35

Edlin, Gordon. "AIDS Pathogenesis". Nature Biotechnology 6, n.º 2 (fevereiro de 1988): 217. http://dx.doi.org/10.1038/nbt0288-217b.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

36

Jackson, Alan C. "Rabies pathogenesis". Journal of Neurovirology 8, n.º 4 (janeiro de 2002): 267–69. http://dx.doi.org/10.1080/13550280290100725.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

37

Nowak, Martin, e Robert M. May. "AIDS pathogenesis". AIDS 7 (janeiro de 1992): S3—S18. http://dx.doi.org/10.1097/00002030-199201001-00002.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

38

Nowak, Martin, e Robert M. May. "AIDS pathogenesis". AIDS 7 (janeiro de 1993): S3—S18. http://dx.doi.org/10.1097/00002030-199301001-00002.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

39

Ross, Christopher A., Jonathan D. Wood, Gabriele Schilling, Matthew F. Peters, Frederick C. Nucifora, Jillian K. Cooper, Alan H. Sharp, Russell L. Margolis e David R. Borchelt. "Polyglutamine pathogenesis". Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 354, n.º 1386 (29 de junho de 1999): 1005–11. http://dx.doi.org/10.1098/rstb.1999.0452.

Texto completo da fonte

Resumo:

An increasing number of neurodegenerative disorders have been found to be caused by expanding CAG triplet repeats that code for polyglutamine. Huntington's disease (HD) is the most common of these disorders and dentato-rubral-pallidoluysian atrophy (DRPLA) is very similar to HD, but is caused by mutation in a different gene, making them good models to study. In this review, we will concentrate on the roles of protein aggregation, nuclear localization and proteolytic processing in disease pathogenesis. In cell model studies of HD, we have found that truncated N-terminal portions of huntingtin (the HD gene product) with expanded repeats form more aggregates than longer or full length huntingtin polypeptides. These shorter fragments are also more prone to aggregate in the nucleus and cause more cell toxicity. Further experiments with huntingtin constructs harbouring exogenous nuclear import and nuclear export signals have implicated the nucleus in direct cell toxicity. We have made mouse models of HD and DRPLA using an N-terminal truncation of huntingtin (N171) and full-length atrophin-1 (the DRPLA gene product), respectively. In both models, diffuse neuronal nuclear staining and nuclear inclusion bodies are observed in animals expressing the expanded glutamine repeat protein, further implicating the nucleus as a primary site of neuronal dysfunction. Neuritic pathology is also observed in the HD mice. In the DRPLA mouse model, we have found that truncated fragments of atrophin-1 containing the glutamine repeat accumulate in the nucleus, suggesting that proteolysis may be critical for disease progression. Taken together, these data lead towards a model whereby proteolytic processing, nuclear localization and protein aggregation all contribute to pathogenesis.

Estilos ABNT, Harvard, Vancouver, APA, etc.

40

Cantor, Jerome O., e Gerard M. Turino. "COPD Pathogenesis". Chest 155, n.º 2 (fevereiro de 2019): 266–71. http://dx.doi.org/10.1016/j.chest.2018.07.030.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

41

Dushku, Nicholas. "Pterygia Pathogenesis". Archives of Ophthalmology 119, n.º 5 (1 de maio de 2001): 695. http://dx.doi.org/10.1001/archopht.119.5.695.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

42

Ahn, Christine S., e William W. Huang. "Rosacea Pathogenesis". Dermatologic Clinics 36, n.º 2 (abril de 2018): 81–86. http://dx.doi.org/10.1016/j.det.2017.11.001.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

43

K.Z., Kadirov, e Isroilov R.I. "ETHIO-PATHOGENESIS OF POUND DESTROYMENT IN CHILDREN". American Journal of Medical Sciences and Pharmaceutical Research 6, n.º 2 (1 de fevereiro de 2024): 75–82. http://dx.doi.org/10.37547/tajmspr/volume06issue02-10.

Texto completo da fonte

Resumo:

Infectious diseases are one of the most serious problems because they are the most widespread and the leading cause of death. Although significant advances have been made over the past decades in addressing this problem, this statement is still true today. Sepsis is the leading cause of death in critical care patients. It develops in 750000 people each year and more than 210000 of them die. Progress in the study of the pathophysiology and genetic basis of the individual response to sepsis has changed the common understanding of this syndrome, and some therapeutic interventions used in recent years have demonstrated efficacy; however, the problem of intensive care is still quite acute and requires further research.

Estilos ABNT, Harvard, Vancouver, APA, etc.

44

Rohilla, Lakshita, Karandeep Singh e Abhijit Garg. "Intranasal Malignantmelanoma: Pathogenesis Epidemiology and Clinical Insight". International Journal of Science and Research (IJSR) 12, n.º 9 (5 de setembro de 2023): 740–44. http://dx.doi.org/10.21275/sr23907100157.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

45

Borozdenko, Denis A., Vladislava I. Bogorodova, Nina M. Kiseleva e Vadim V. Negrebetsky. "Parkinson’s disease: epidemiology and pathogenesis". Medical Journal of the Russian Federation 27, n.º 2 (23 de julho de 2021): 183–94. http://dx.doi.org/10.17816/0869-2106-2021-27-2-183-194.

Texto completo da fonte

Resumo:

This review presents data on the etiology, epidemiology, and pathogenesis of Parkinsons disease from National Center for Biotechnology Information (NCBI), eLibrary, CyberLeninka, and from monographs and textbooks. The prevalence, classification, genetic variability, main pathogenetic links, and potential disease development mechanisms are described. Both classic Parkinsons disease and variable manifestations of parkinsonism are considered. The factors that contribute to disease progression and inhibit its development are described. The main hypotheses of the pathogenetic mechanisms of Parkinsons disease are presented. These are protein misfolding, mitochondrial dysfunction, impaired protein purification systems, neuroinflammation, and pathology of the gut-brain axis.

Estilos ABNT, Harvard, Vancouver, APA, etc.

46

Varghese, Smitha Ancy. "Secondary lymphedema: Pathogenesis". Journal of Skin and Sexually Transmitted Diseases 3 (6 de abril de 2021): 7–15. http://dx.doi.org/10.25259/jsstd_3_2020.

Texto completo da fonte

Resumo:

Secondary lymphedema follows an acquired defect in the lymphatic system. The common causes leading to a defective lymphatic function include infection, inflammation, malignancy, trauma, obesity, immobility, and therapeutic interventions. Understanding the pathogenesis of lymphedema is of prime importance in offering effective treatment. The pathogenetic mechanisms such as lymphatic valvular insufficiency, obliteration/ disruption of lymphatic vessels, and decreased lymphatic contractility aggravate lymphatic hypertension and lymphstasis. Accumulation of lymph, interstitial fluid, proteins, and glycosaminoglycans within the skin and subcutaneous tissue eventually stimulates collagen production by fibroblasts, causes disruption of elastic fibers, and activates keratinocytes, fibroblasts, and adipocytes. These result in thickening of skin and cause fibrosis of subcutaneous tissue. However, the sequence of these pathomechanisms, their inter-relationship and progression vary depending on the specific etiology of the lymphedema. In this article, we discuss the possible cellular and molecular mechanisms involved in the pathogenesis. Further studies to delineate the exact sequence of pathogenic processes surrounding the primary triggering event can help to formulate tailored therapeutic approaches.

Estilos ABNT, Harvard, Vancouver, APA, etc.

47

Varghese, Smitha Ancy. "Secondary lymphedema: Pathogenesis". Journal of Skin and Sexually Transmitted Diseases 3 (6 de abril de 2021): 7–15. http://dx.doi.org/10.25259/jsstd_3_2021.

Texto completo da fonte

Resumo:

Secondary lymphedema follows an acquired defect in the lymphatic system. The common causes leading to a defective lymphatic function include infection, inflammation, malignancy, trauma, obesity, immobility, and therapeutic interventions. Understanding the pathogenesis of lymphedema is of prime importance in offering effective treatment. The pathogenetic mechanisms such as lymphatic valvular insufficiency, obliteration/ disruption of lymphatic vessels, and decreased lymphatic contractility aggravate lymphatic hypertension and lymphstasis. Accumulation of lymph, interstitial fluid, proteins, and glycosaminoglycans within the skin and subcutaneous tissue eventually stimulates collagen production by fibroblasts, causes disruption of elastic fibers, and activates keratinocytes, fibroblasts, and adipocytes. These result in thickening of skin and cause fibrosis of subcutaneous tissue. However, the sequence of these pathomechanisms, their inter-relationship and progression vary depending on the specific etiology of the lymphedema. In this article, we discuss the possible cellular and molecular mechanisms involved in the pathogenesis. Further studies to delineate the exact sequence of pathogenic processes surrounding the primary triggering event can help to formulate tailored therapeutic approaches.

Estilos ABNT, Harvard, Vancouver, APA, etc.

48

Nedelea, Irena, e Diana Deleanu. "Food allergy – pathogenesis". Alergologia 1, n.º 3 (2019): 9. http://dx.doi.org/10.26416/aler.3.1.2019.2263.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

49

Offenbacher, Steven. "Periodontal Diseases: Pathogenesis". Annals of Periodontology 1, n.º 1 (novembro de 1996): 821–78. http://dx.doi.org/10.1902/annals.1996.1.1.821.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

50

Tainwala, Ram, e YK Sharma. "Pathogenesis of dermatophytoses". Indian Journal of Dermatology 56, n.º 3 (2011): 259. http://dx.doi.org/10.4103/0019-5154.82476.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!